Medical Devices
-
Abbott lowers earnings forecast after $21B Exact Sciences buy
CEO Robert Ford said the companies are a good cultural fit and he expects demand for Exact’s colon cancer screening test to increase.
By Elise Reuter • April 16, 2026 -
Boston Scientific plans $88.5M R&D expansion in Ireland
The device maker plans to invest 75 million euros into expanding the site, with a focus on cardiovascular innovation.
By Elise Reuter • April 16, 2026 -
Explore the Trendline➔
Courtesy of Intuitive Surgical
TrendlineTop 5 stories from MedTech Dive
From the top medtech trends to watch in 2026 to haphazard layoffs at the Food and Drug Administration and the evolving use of AI in the medtech sector, here is a collection of top stories from MedTech Dive.
By MedTech Dive staff -
Medtronic confirms paclitaxel balloon’s efficacy in post-approval trial
The end-stage kidney disease device performed as well in the study as in a pivotal trial that supported FDA approval.
By Nick Paul Taylor • April 16, 2026 -
Stereotaxis to buy Robocath for up to $45M
The deal combines Stereotaxis’ magnetic navigation technology and Robocath’s mechanical robotic system, strengthening the company’s position in endovascular surgery, said CEO David Fischel.
By Susan Kelly • April 15, 2026 -
AIP to acquire Avanos Medical in $1.27B go-private deal
Avanos Medical generated $701.2 million last year from sectors where it competes with Boston Scientific, Medtronic and Stryker.
By Nick Paul Taylor • April 15, 2026 -
Medline recalls angiographic syringes, receives FDA warning letter
The company removed the devices from the market in February following complaints of the syringes disconnecting from manifolds.
By Elise Reuter • April 14, 2026 -
GE HealthCare integrates ultrasound into Medtronic’s Stealth AXiS surgical system
Partnering with GE HealthCare has enabled Medtronic to provide live images to help surgeons assess mid-procedure changes.
By Nick Paul Taylor • April 13, 2026 -
Stryker to buy Amplitude Vascular Systems
Amplitude’s intravascular lithotripsy technology could emerge as a challenger to Shockwave IVL, Leerink Partners analyst Mike Kratky wrote.
By Elise Reuter • April 13, 2026 -
Sponsored by PAXXUS
The seal strength paradox: Why more is not always better in sterile barrier packaging
What really determines seal performance in sterile packaging?
April 13, 2026 -
Pulse Biosciences hires Liane Teplitsky as COO
The appointment gives a former Abbott leader oversight of efforts to bring a pulsed field ablation device to market.
By Nick Paul Taylor • April 10, 2026 -
E2 raises $80M to market thrombectomy platform
The funding round follows high-profile acquisitions by Boston Scientific and Stryker to pick up mechanical thrombectomy devices for blood clot removal.
By Susan Kelly • April 9, 2026 -
FDA, medtech industry near MDUFA VI agreement
The FDA said it intends to hire “substantial numbers” of medical device review staff as part of the agreement for the next medical device user fee amendments.
By Elise Reuter • April 9, 2026 -
CDRH targets hospital readmissions with home device innovation challenge
The center plans to pick nine devices to help support patients and caregivers after a hospital stay.
By Elise Reuter • April 9, 2026 -
Deep Dive
One year in: How medtech companies are coping with tariff challenges
A resilient medtech industry navigating the fallout from President Donald Trump’s trade wars is taking proactive steps to manage tariff costs as the administration’s policies continue to evolve.
By Susan Kelly • April 9, 2026 -
Philips warns not to use certain nebulizers in Trilogy Evo ventilator recall
Using non-pneumatic nebulizers with the ventilators can lead to under-delivery of therapy to patients, the company said.
By Elise Reuter • Updated April 9, 2026 -
Hologic hires former Baxter leader José Almeida as CEO
The company appointed Almeida as chief executive in conjunction with the completion of an $18.3 billion go-private deal.
By Nick Paul Taylor • April 8, 2026 -
Zimmer hires chief science, technology and medical affairs officer
Jonathan Vigdorchik, an orthopedic surgeon from the Hospital for Special Surgery, previously was chief medical technology adviser for the company.
By Elise Reuter • April 7, 2026 -
J&J launches enhanced PFA device in Europe
The Varipulse Pro pulsed field ablation platform, which has received a CE mark, will be a focus at the upcoming European Heart Rhythm Association annual meeting in Paris.
By Susan Kelly • April 7, 2026 -
UK steps up push to align medtech regulations with the US
Health regulators on both sides of the Atlantic are assessing alignment opportunities and exploring mutual recognition mechanisms.
By Nick Paul Taylor • April 7, 2026 -
VDyne secures FDA nod to start pivotal trial for tricuspid valve
With approval to study the transcatheter replacement device in patients with severe tricuspid regurgitation, VDyne is advancing a treatment to compete with Edwards Lifesciences’ Evoque system.
By Susan Kelly • April 6, 2026 -
Retrieved from Hologic on April 06, 2026
Hologic CEO Steve MacMillan to retire after go-private deal
The $18.3 billion acquisition by Blackstone and TPG is expected to close Tuesday.
By Elise Reuter • April 6, 2026 -
Boston Scientific closes buyout of Valencia Technologies
The deal positions Boston Scientific to compete with Medtronic for a market that analysts believe is highly under-penetrated.
By Nick Paul Taylor • April 6, 2026 -
Scientists urge EPA not to weaken ethylene oxide emissions standards
Scientists, clinicians and residents of communities near medical device sterilization plants called for the EPA not to weaken its oversight of ethylene oxide in a public hearing.
By Elise Reuter • April 3, 2026 -
Restore Robotics cleared to remanufacture 2 more da Vinci Xi instruments
The remanufacturer said it now has a total of four clearances for Intuitive Surgical da Vinci instruments from the Food and Drug Administration.
By Susan Kelly • April 3, 2026 -
Merit Medical acquires View Point for $140M
View Point sells tumor tissue localization devices that could complement Merit’s existing presence in the sector.
By Nick Paul Taylor • April 2, 2026